Tag: Tinnitus

Research Shows Hearing Issues Common in Cancer Survivors

While children receiving chemotherapy routinely undergo hearing tests, adults don’t, and a new study by UC San Francisco (UCSF) reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer. The researchers found that more than half the survivors in their study who had been treated with chemotherapy experienced significant hearing problems.

Read More

Neuromod Publishes Clinical Trial for Lenire Device

An international team, including a University of Minnesota professor, has published a second large clinical trial for a novel neuromodulation device, Lenire, that could reduce symptoms for millions worldwide with tinnitus, commonly described as “ringing in the ears.”  Researchers published the results of the Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2 (TENT-A2) clinical trial in “Nature – Scientific Reports.” An article detailing the research appears on the University of Minnesota website.

Read More

Neuromod Announces Lenire Tinnitus Study Results

Neuromod Devices Ltd announced the findings of an independent study performed at the German Hearing Center (DHZ) at Hannover Medical School, which found that 85% of tinnitus patients experienced a reduction in their tinnitus symptoms (based on the Tinnitus Handicap Inventory score[i] across 20 patients) when using the Lenire treatment device. 

Read More
Loading